RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.

Abstract : The POS-1 murine model of osteolytic osteosarcoma was used to elucidate the molecular and cellular mechanisms involved in the development of primary bone tumors and associated lung metastasis. The POS-1 cell line is derived from an osteosarcoma tumor which develops spontaneously in C3H mice. The POS-1 cell line was characterized in vitro by mineralization capacity and expression of bone markers by semi-quantitative RT-PCR, compared to primary osteoblasts and bone marrow cells. POS-1 cells showed no mineralization capacity and exhibited an undifferentiated phenotype, expressing both osteoblastic and unexpected osteoclastic markers (TRAP, cathepsin K and RANK). Thereby, experiments were performed to determine whether RANK was functional, by studying the biological activity of murine RANKL through the receptor RANK expressed on POS-1 cells. Results revealed a RANKL-induced increase in ERK phosphorylation, as well as BMP-2 induction at the mRNA and protein levels, and a decrease of POS-1 cell proliferation in the presence of 10 ng/ml RANKL. BMP-2 induction is dependent on the ERK 1/2 signal transduction pathway, as its expression is abolished in the presence of UO126, a specific synthetic inhibitor of the ERK 1/2 pathway. Moreover, a 2-fold molar excess of soluble RANK blocks the RANKL-induced BMP-2 expression, demonstrating that the biological effects of RANKL observed in POS-1 cells are mediated by RANK. This is the first report describing a functional RANK expressed on osteosarcoma cells, as shown by its ability to induce signal transduction pathways and biological activity when stimulated by RANKL.
Type de document :
Article dans une revue
International Journal of Oncology, Spandidos Publications, 2006, 28 (1), pp.261-9
Liste complète des métadonnées

Littérature citée [31 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00667510
Contributeur : D* Heymann <>
Soumis le : mardi 7 février 2012 - 18:02:54
Dernière modification le : jeudi 5 avril 2018 - 10:36:26
Document(s) archivé(s) le : mardi 8 mai 2012 - 02:36:32

Fichier

Wittrant_et_al_Int_J_Oncol_200...
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

  • HAL Id : inserm-00667510, version 1
  • PUBMED : 16328004

Collections

Citation

Yohann Wittrant, François Lamoureux, Kanji Mori, Anne Riet, Akira Kamijo, et al.. RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.. International Journal of Oncology, Spandidos Publications, 2006, 28 (1), pp.261-9. 〈inserm-00667510〉

Partager

Métriques

Consultations de la notice

248

Téléchargements de fichiers

173